James E Crowe Selected Research

ADM03820

3/2022

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Crowe Research Topics

Disease

114	Infections 05/2024 - 04/2003
32	Human Influenza (Influenza) 01/2023 - 06/2003
22	COVID-19 05/2024 - 01/2020
19	Virus Diseases (Viral Diseases) 11/2023 - 04/2005
16	Dengue (Dengue Fever) 12/2022 - 03/2012
12	Respiratory Syncytial Virus Infections 05/2023 - 07/2003
11	Ebola Hemorrhagic Fever 01/2021 - 01/2016
9	Severe Dengue 12/2018 - 03/2012
7	Communicable Diseases (Infectious Diseases) 01/2022 - 05/2013
6	Reinfection 01/2022 - 08/2014
6	Smallpox (Variola) 07/2008 - 04/2004
5	Coinfection 01/2023 - 03/2007
5	Inflammation (Inflammations) 01/2021 - 01/2020
5	Vaccinia 10/2019 - 09/2004
4	Hantavirus Infections 01/2023 - 01/2021
4	Zika Virus Infection 10/2020 - 01/2017
4	Neoplasms (Cancer) 09/2020 - 06/2003
3	Weight Loss (Weight Reduction) 05/2020 - 01/2015
3	Convalescence 01/2019 - 04/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 05/2016 - 01/2007
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016 - 03/2004
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2023 - 01/2020
2	Breakthrough Infections 01/2022 - 07/2021
2	Persistent Infection 01/2022 - 02/2016
2	Staphylococcal Infections 11/2021 - 12/2010
2	West Nile Fever 10/2021 - 01/2019
2	Alphavirus Infections 11/2020 - 01/2018
2	Viremia 01/2019 - 06/2017
2	Arthritis (Polyarthritis) 01/2019 - 01/2017
2	Filoviridae Infections 01/2018 - 01/2018
2	HIV Infections (HIV Infection) 01/2016 - 01/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2012 - 01/2010
1	Renal Insufficiency (Renal Failure) 01/2023
1	Vesicular Stomatitis 01/2022
1	Sepsis (Septicemia) 01/2022
1	Disease Progression 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Lung Diseases (Lung Disease) 12/2020
1	Coronavirus Infections 12/2020
1	Flavivirus Infections 10/2020

Drug/Important Bio-Agent (IBA)

64	AntibodiesIBA 11/2023 - 09/2008
62	Monoclonal AntibodiesIBA 05/2024 - 07/2008
54	VaccinesIBA 05/2024 - 06/2003
40	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
34	EpitopesIBA 01/2023 - 04/2003
31	Neutralizing AntibodiesIBA 11/2023 - 09/2008
13	Glycoproteins (Glycoprotein)IBA 04/2024 - 07/2015
13	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 03/2010
12	Broadly Neutralizing AntibodiesIBA 05/2024 - 07/2010
10	AntigensIBA 01/2023 - 04/2003
10	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2011
9	Immunoglobulin G (IgG)IBA 01/2022 - 06/2003
8	CytokinesIBA 06/2017 - 04/2004
7	Messenger RNA (mRNA)IBA 12/2022 - 08/2012
7	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2009
6	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2007
5	Neuraminidase (Sialidase)IBA 12/2019 - 10/2012
5	Polysaccharides (Glycans)IBA 01/2019 - 01/2018
4	Peptides (Polypeptides)IBA 10/2020 - 03/2007
4	Dengue VaccinesIBA 01/2019 - 06/2013
4	Blocking AntibodiesIBA 01/2018 - 03/2012
4	Fc Receptors (Fc Receptor)IBA 01/2018 - 03/2012
3	cilgavimab and tixagevimab drug combinationIBA 05/2024 - 01/2022
3	COV2-2130IBA 04/2023 - 01/2020
3	Ebola VaccinesIBA 01/2021 - 01/2019
3	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2020 - 12/2009
3	MucinsIBA 01/2019 - 05/2009
2	IronIBA 01/2019 - 12/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 03/2002
2	Immune Sera (Antisera)IBA 01/2019 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2012
2	Carrier Proteins (Binding Protein)IBA 04/2015 - 12/2010
2	InterferonsIBA 08/2012 - 04/2004
2	Viral RNAIBA 12/2010 - 05/2009
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2010 - 05/2009
2	EnzymesIBA 07/2008 - 03/2007
2	Aventis Pasteur smallpox vaccineIBA 03/2005 - 09/2004
1	2019-nCoV Vaccine mRNA-1273IBA 05/2024
1	COVID-19 VaccinesIBA 05/2024
1	AerosolsIBA 11/2023
1	Explosive Agents (Explosives)IBA 10/2023
1	Recombinant ProteinsIBA 10/2023
1	cilgavimabIBA 04/2023
1	ADM03820IBA 03/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	OMPA outer membrane proteinsIBA 01/2022
1	PorinsIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	Photosensitizing Agents (Photosensitizers)IBA 11/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Sulfates (Sulfates, Inorganic)IBA 01/2021
1	atoltivimabIBA 01/2021
1	odesivimabIBA 01/2021
1	Subgenomic RNAIBA 01/2021
1	maftivimabIBA 01/2021
1	ansuvimabIBA 01/2021

Therapy/Procedure

23	Therapeutics 01/2023 - 03/2002
2	Hematopoietic Stem Cell Transplantation 03/2012 - 01/2010
1	Nebulizers and Vaporizers (Inhaler) 12/2022